A randomised, open-label, 4-period crossover, phase I clinical trial of various oral formulations of omecamtiv mecarbil in healthy volunteers.

Trial Profile

A randomised, open-label, 4-period crossover, phase I clinical trial of various oral formulations of omecamtiv mecarbil in healthy volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 28 Dec 2015

At a glance

  • Drugs Omecamtiv mecarbil (Primary)
  • Indications Angina pectoris; Cardiomyopathies; Heart failure
  • Focus Pharmacokinetics
  • Most Recent Events

    • 28 Dec 2015 Results published in the International Journal of Clinical Pharmacology and Therapeutics
    • 01 Jul 2012 Status changed from recruiting to completed.
    • 21 Feb 2012 Planned number of subjects is 60, according to a Cytokinetics Media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top